scholarly journals THE DESCRIBED SPECIES OF XIPHIDIUM IN THE UNITED STATES AND CANADA

1898 ◽  
Vol 30 (7) ◽  
pp. 183-184
Author(s):  
Samuel H. Scudder

The following table made as simple as possible, and based almost exclusively upon the female sex, will serve to distinguish the species of Xiphidium hitherto described or recorded from the United States and Canada. It included only the species of Xiphidium proper; i. e., those of slender form with straight or nearly straight ovipositor, excluding the stouter species with distinctly arcuate ovipositor, commonly referred to Orchelimum, though both are classed together by Redtenbacher.

Blood ◽  
1955 ◽  
Vol 10 (12) ◽  
pp. 1214-1227 ◽  
Author(s):  
MICHAEL B. SHIMKIN

Abstract Mortality from Hodgkin’s disease in the United States during the period 1921 through 1951 was analyzed with respect to race, sex and age incidence and distribution. The findings were compared with those reported for leukemia. The recorded death rate from Hodgkin’s disease rose from 6.9 in 1921 to 17.0 per million in 1951. During this period, the death rate from leukemia rose from 14 to 61 per million. The death rate among males is higher than among females for both diseases; the male predominance is more marked in Hodgkin’s disease than in leukemia. The rate is higher among whites than non-whites for both diseases; the white predominance is more marked in leukemia than in Hodgkin’s disease. There is no peak in rate during childhood for Hodgkin’s disease as there is for leukemia, and the increase in rate with age is much less steep for Hodgkin’s disease than for leukemia. The mean age at death of adults dying from Hodgkin’s disease and from leukemia increased by 3.5 and 8.0 years, respectively, between 1925 and 1950. The male-female sex ratio for Hodgkin’s disease decreased slightly, and increased slightly for leukemia between 1925 and 1950.


2015 ◽  
Vol 19 (12) ◽  
pp. 2380-2380
Author(s):  
Neetu Abad ◽  
Brittney N. Baack ◽  
Ann O’Leary ◽  
Yuko Mizuno ◽  
Jeffrey H. Herbst ◽  
...  

2015 ◽  
Vol 19 (9) ◽  
pp. 1701-1719 ◽  
Author(s):  
Neetu Abad ◽  
Brittney N. Baack ◽  
Ann O’Leary ◽  
Yuko Mizuno ◽  
Jeffrey H. Herbst ◽  
...  

2020 ◽  
Author(s):  
Bradley Silberzahn ◽  
Catherine A. Tomko ◽  
Emily Clouse ◽  
Katherine Haney ◽  
Sean T. Allen ◽  
...  

BACKGROUND Cisgender female sex workers (FSW) experience high rates of HIV and sexually transmitted infections (STIs) including chlamydia and gonorrhea. Community empowerment-based responses to the risk environment of female sex workers have been associated with significant reductions in HIV/STI risk and associated risk behaviors, yet evaluations of U.S. based interventions targeting FSW are limited. OBJECTIVE We describe the design, implementation, and evaluation of an ongoing comprehensive community-level intervention targeting FSW in Baltimore City, Maryland. METHODS The two intervention components are the SPARC drop-in center and the accompanying comprehensive mobile outreach program (in the west Baltimore area). The mission of SPARC is to provide low-barrier harm reduction services to at-risk non-men, with a special focus on women who sell sex and use drugs. SPARC addresses clients’ needs through nonjudgmental, convenient, safe, and non-stigmatizing interactions. Services are provided through a harm reduction framework and include: reproductive health and sexual health screenings; medication assisted treatment; legal aid, counseling; showers, lockers, laundry; and the distribution of harm reduction tools including naloxone and sterile drug use supplies (e.g., cookers, cotton, syringes, pipes). The SPARC intervention is being evaluated through the EMERALD study, which consists of: a prospective two-group comparative non-randomized trial (n=385); a cross sectional survey (n=100); and in-depth interviews assessing SPARC implementation (n=45). Participants enrolled in the non-randomized trial complete a survey and HIV/STI testing at four intervals (baseline, 6-, 12-, 18-months). Participants recruited from pre-defined areas closest to SPARC comprised the intervention group, and participants from all other areas of Baltimore were in the control. RESULTS We hypothesize that addressing structural drivers and more immediate medical needs, in combination with peer outreach, will lead to community empowerment and reduce FSWs’ HIV/STI cumulative incidence and behavioral risks. CONCLUSIONS In the United States, structural interventions aimed to reduce HIV and STIs among FSW are scarce, and to our knowledge this is the first intervention of its kind in the United States. The results of the EMERALD study can be used to inform the development of future interventions targeting FSW and other at-risk populations. CLINICALTRIAL NCT04413591


2019 ◽  
Vol 40 (36) ◽  
pp. 3035-3043 ◽  
Author(s):  
Jim W Cheung ◽  
Edward P Cheng ◽  
, Xian Wu ◽  
Ilhwan Yeo ◽  
Paul J Christos ◽  
...  

Abstract Aims Although catheter ablation has emerged as an important therapy for patients with symptomatic atrial fibrillation (AF), there are limited data on sex-based differences in outcomes. We sought to compare in-hospital outcomes and 30-day readmissions of women and men undergoing AF ablation. Methods and results Using the United States Nationwide Readmissions Database, we analysed patients undergoing AF ablation between 2010 and 2014. Based on ICD-9-CM codes, we identified co-morbidities and outcomes. Multivariable logistic regression and inverse probability-weighting analysis were performed to assess female sex as a predictor of endpoints. Of 54 597 study patients, 20 623 (37.7%) were female. After adjustment for age, co-morbidities, and hospital factors, women had higher rates of any complication [adjusted odds ratio (aOR) 1.39; P < 0.0001], cardiac perforation (aOR 1.39; P = 0.006), and bleeding/vascular complications (aOR 1.49; P < 0.0001). Thirty-day all-cause readmission rates were higher for women compared to men (13.4% vs. 9.4%; P < 0.0001). Female sex was independently associated with readmission for AF/atrial tachycardia (aOR 1.48; P < 0.0001), cardiac causes (aOR 1.40; P < 0.0001), and all causes (aOR 1.25; P < 0.0001). Similar findings were confirmed with inverse probability-weighting analysis. Despite increased complications and readmissions, total costs for AF ablation were lower for women than men due to decreased resource utilization. Conclusions Independent of age, co-morbidities, and hospital factors, women have higher rates of complications and readmissions following AF ablation. Sex-based differences and disparities in the management of AF need to be explored to address these gaps in outcomes.


1906 ◽  
Vol 38 (9) ◽  
pp. 305-307 ◽  
Author(s):  
Alex. D. Macgillivray

There have been described thus far three species of this genus from the United States, two of them known only in the male sex, the third known only in the female sex. A fourth species, known only in the female sex, is described below. The types of œqualis, Nort., and simplocicornis, Cress., are in the collections of the American Entomological Society, and I am indebted to Mr. J. Chester Bradley for examining these types and furnishing me with the notes on which the descriptions given below are based.


Author(s):  
A. Hakam ◽  
J.T. Gau ◽  
M.L. Grove ◽  
B.A. Evans ◽  
M. Shuman ◽  
...  

Prostate adenocarcinoma is the most common malignant tumor of men in the United States and is the third leading cause of death in men. Despite attempts at early detection, there will be 244,000 new cases and 44,000 deaths from the disease in the United States in 1995. Therapeutic progress against this disease is hindered by an incomplete understanding of prostate epithelial cell biology, the availability of human tissues for in vitro experimentation, slow dissemination of information between prostate cancer research teams and the increasing pressure to “ stretch” research dollars at the same time staff reductions are occurring.To meet these challenges, we have used the correlative microscopy (CM) and client/server (C/S) computing to increase productivity while decreasing costs. Critical elements of our program are as follows:1) Establishing the Western Pennsylvania Genitourinary (GU) Tissue Bank which includes >100 prostates from patients with prostate adenocarcinoma as well as >20 normal prostates from transplant organ donors.


Sign in / Sign up

Export Citation Format

Share Document